Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth J Rothman

Showing results (291-300 of 360) with videos related to

Pageof 36
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 16, 2022
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF RegistryGregory Y H Lip, Agnieszka Kotalczyk, Christine Teutsch, et al.
The Journal of Clinical Endocrinology and Metabolism|September 25, 2018
Cardiovascular Safety During and After Use of Phentermine and TopiramateMary E Ritchey, Abenah Harding, Shannon Hunter, et al.
Journal of the American Academy of Dermatology|September 30, 2014
OBSERVE-5: observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year resultsAlexa B Kimball, Kenneth J Rothman, Gregory Kricorian, et al.
Pharmacoepidemiology and Drug Safety|March 25, 2023
Pragmatic considerations for negative control outcome studies to guide non-randomized comparative analyses: A narrative reviewSara N Levintow, Carrie M Nielson, Rohini K Hernandez, et al.
Environmental Epidemiology (Philadelphia, Pa.)|March 29, 2021
Residential proximity to major roads and fecundability in a preconception cohortAmelia K Wesselink, Kipruto Kirwa, Elizabeth E Hatch, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 24, 2016
Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohortMenno V Huisman, Chang Sheng Ma, Hans-Christoph Diener, et al.
The American Journal of Medicine|August 5, 2015
Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase IIMenno V Huisman, Kenneth J Rothman, Miney Paquette, et al.
Journal of Arrhythmia|June 13, 2020
Stroke prevention in atrial fibrillation changes after dabigatran availability in China: The GLORIA-AF registryChangsheng Ma, Lionel Riou França, Shihai Lu, et al.
Paediatric and Perinatal Epidemiology|December 16, 2019
At-home sperm testing for epidemiologic studies: Evaluation of the Trak male fertility testing system in an internet-based preconception cohortGreg J Sommer, Tanran R Wang, Jon G Epperson, et al.
The American Journal of Medicine|April 15, 2018
Gender Differences in Antithrombotic Treatment for Newly Diagnosed Atrial Fibrillation: The GLORIA-AF Registry ProgramMichał Mazurek, Menno V Huisman, Kenneth J Rothman, et al.
Pageof 36

Showing results (291-300 of 360) with videos related to

Sort By:
Pageof 36
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 16, 2022
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF RegistryGregory Y H Lip, Agnieszka Kotalczyk, Christine Teutsch, et al.
The Journal of Clinical Endocrinology and Metabolism|September 25, 2018
Cardiovascular Safety During and After Use of Phentermine and TopiramateMary E Ritchey, Abenah Harding, Shannon Hunter, et al.
Journal of the American Academy of Dermatology|September 30, 2014
OBSERVE-5: observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year resultsAlexa B Kimball, Kenneth J Rothman, Gregory Kricorian, et al.
Pharmacoepidemiology and Drug Safety|March 25, 2023
Pragmatic considerations for negative control outcome studies to guide non-randomized comparative analyses: A narrative reviewSara N Levintow, Carrie M Nielson, Rohini K Hernandez, et al.
Environmental Epidemiology (Philadelphia, Pa.)|March 29, 2021
Residential proximity to major roads and fecundability in a preconception cohortAmelia K Wesselink, Kipruto Kirwa, Elizabeth E Hatch, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 24, 2016
Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohortMenno V Huisman, Chang Sheng Ma, Hans-Christoph Diener, et al.
The American Journal of Medicine|August 5, 2015
Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase IIMenno V Huisman, Kenneth J Rothman, Miney Paquette, et al.
Journal of Arrhythmia|June 13, 2020
Stroke prevention in atrial fibrillation changes after dabigatran availability in China: The GLORIA-AF registryChangsheng Ma, Lionel Riou França, Shihai Lu, et al.
Paediatric and Perinatal Epidemiology|December 16, 2019
At-home sperm testing for epidemiologic studies: Evaluation of the Trak male fertility testing system in an internet-based preconception cohortGreg J Sommer, Tanran R Wang, Jon G Epperson, et al.
The American Journal of Medicine|April 15, 2018
Gender Differences in Antithrombotic Treatment for Newly Diagnosed Atrial Fibrillation: The GLORIA-AF Registry ProgramMichał Mazurek, Menno V Huisman, Kenneth J Rothman, et al.
Pageof 36